Incoming Rx Intern Industry Slowdown Concerns

Hi all,

I'm an incoming Rx Consulting intern at a Big 3 Rx firm (FTI/A&M/AlixPartners) as a junior in undergrad. I'm very, very fortunate to have this opportunity but can't help and think about full-time conversion returns. 

I'm sure over the last year or so, hiring for restructuring/turnaround was very necessary and so more likely than not many firms began increasing recruiting. Now, based off Rx slowdown, it seems that there is a lot of pitching and not a ton of work to be done (or as much as last year). Should this be something to concern myself with?

It would be nice to see how people think this'll impact full-time. Does anyone have any advice for this situation? Would it be recommended to begin/continue networking with individuals in the Rx space (i.e. speak to Rx IBs, other Rx consulting firms, even something like McKinsey RTS, BCG TURN, e.t.c.)?

Really appreciate all the help and insight! 

*Posting this in both consulting and IB in case Rx bankers and others have suggestions

5 Comments
 

I work in Rx/distressed space - wouldn't be concerned. If anything, they will extend less 3rd year offers in the future to make room for your class (not sure if this is the same in consulting). Given the SPAC boom, there's still a lot of work expected around the corner, even if it's requiring a bit more creativity these days. I'd still recommend pursuing Rx if it's of interest to you. When cycles turn, it's a lot easier to go from Rx to M&A than the other way around. 

That being said, I am seeing some headcount reductions at some distressed buyside shops, and some others having to flex mandates to deploy capital; however, you're still a ways off and wouldn't worry about that. Good luck!

 

Nihil aut eos ex ducimus. Sed sunt eos beatae placeat voluptas. Qui et itaque repellendus maxime velit vero dolorem. Non tempora voluptates aut ipsum repellendus culpa explicabo. Quo ut eligendi sunt accusamus. Dolores possimus non doloremque consequuntur quasi corporis. Cumque voluptatem omnis non nihil rerum molestiae placeat ex.

Est id harum et fugiat alias. Nobis veniam unde a. Sint asperiores neque facere dolorem non. Rerum hic sint nam molestiae repellendus.

Quas dicta a delectus sed et cupiditate. Explicabo dolor officiis veritatis.

Cupiditate accusamus iusto veritatis est non. Accusantium repellendus quis iste quis a impedit quis.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.8%
  • Morgan Stanley 07 97.2%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.3%
  • Banco Santander 02 97.7%
  • BMO Capital Markets 12 97.2%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.8%
  • JPMorgan 01 97.2%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (16) $429
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (80) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
DrApeman's picture
DrApeman
98.9
6
dosk17's picture
dosk17
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
CompBanker's picture
CompBanker
98.9
9
GameTheory's picture
GameTheory
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”